GREATBIO TECHNOLOGIES INC
NTN 10Q, 2001-01-10
BLANK CHECKS
Previous: THERMOVIEW INDUSTRIES INC, SC 13D, 2001-01-10
Next: CASSIDY JAMES M, SC 13G/A, 2001-01-10























TABLE OF CONTENTS

NT-10-Q

PART I	        1
PART III	2
PART IV	        2

                            UNITED STATES
                  SECURITIES AND EXCHANGE COMMISSION
                        Washington, D.C. 20549

                             FORM 12b-25

                     NOTIFICATION OF LATE FILING
                                                SEC File No. 0-26057
(Check One):                             CUSIP Number: 391540 10 1
  Form 10-KSB    Form 20-F     Form 11-K    [X] Form 10-Q     Form N-SAR

          For Period Ended:  May 31, 2000
               Transition Report on Form 10-K
               Transition Report on Form 20-F
               Transition Report on Form 11-K
               Transition Report on Form 10-Q
               Transition Report on Form N-SAR
               For the Transition Period Ended:

Nothing in this form shall be construed to imply that the Commission
has verified any information contained herein.

If the notification relates to a portion of the filing checked above,
identify the item(s) to which the notification relates:

PART I - REGISTRATION INFORMATION

Full Name of Registrant: GreatBio Technologies, Inc.

Former Name if Applicable:  Idaho Technical, Inc.
                            Idaho Copper and Gold, Inc.

Address of Principal Executive Office
Street and Number           Tech Enterprise Center, Suite 201
                            150 Lucius Gordon Drive
City, State and Zip Code:   West Henrietta, NY 14586


PART II - RULES 12b-25(b) AND (c)

If the subject report could not be filed without unreasonable effort or
expense and the registrant seeks relief pursuant to Rule 12b-25(b), the
following should be completed.  (Check box if appropriate)
  X
               (a)  The reasons described in reasonable detail in Part III of
          this form could not be eliminated without unreasonable effort
          or expense;
               (b)  The subject annual report, semi-annual report, transition
          report on Form 10-K, Form 20-F, 11-K or Form N-SAR, or
          portion thereof, will be filed on or before the fifteenth
          calendar following the prescribed due date; or the subject
          quarterly report or transition report on Form 10-Q, or
          portion thereof will be filed on the or before the fifth
          calendar day following the prescribed due date: and
               (c)  The accountant's statement or other exhibit required by
          Rule 12b-25(c) has been attached if applicable.

PART III - NARRATIVE

State below in reasonable detail the reasons why Forms 10-K, 20-F, 11-
K, 10-Q, N-SAR, or the transition report or portion thereof, could not
be filed within the prescribed time period.

Financial statements are being finalized and report will be filed within
extension period.
<PAGE>
PART IV - OTHER INFORMATION

     (1)  Name and telephone number of person to contact in regard to this
     notification.

          David A. Miller          (208)            263-8179
               (Name)              (Area Code)    (Telephone Number)

     (2)  Have all other periodic reports required under Section 13 or 15(d)
     of the Securities Exchange Act of 1934 or Section 30 of the
     Investment Company Act of 1940 during the preceding 12 months or
     for such shorter period that the registrant was required to file
     such report(s) been filed?  If answer is not, identify reports(s).
                              Yes X     No

     (3)  Is it anticipated that any significant change in results of
     operations from the corresponding period for the last fiscal year
     will be reflected by the earnings statements to be included in the
     subject report or portion thereof?      Yes       No X

          If so, attach an explanation of the anticipated change, both
     narratively and quantitatively, and, if appropriate, state the
     reasons why a reasonable estimate of the results cannot be made.

                     GreatBio Technologies, Inc.
             (Name of Registrant as Specified in Charter)

has caused this notification to be signed on its behalf by the
undersigned hereunto duly authorized.

Date:  January 10, 2001         By: /S/ Micheal L. Weiner
                                        (Signature)
                                    Micheal L. Weiner President

INSTRUCTION:  The form may be signed by an executive officer of the
registrant or by any other duly authorized representative.  The name
and title of the person signing the form shall be typed or printed
beneath the signature.  If the statement is signed on behalf of the
registrant by an authorized representative (other than an executive
officer), evidence of the representative's authority to sign on behalf
of the registrant shall be filed with the form.

                              ATTENTION
Intentional misstatements or omissions of fact constitute Federal
Criminal Violations (See 18 U.S.C. 1001).



<PAGE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission